Aclaris Therapeutics | SC 13G:超過5%持股股東披露文件-Rock Springs Capital Management LP(6.32%),Rock Springs Capital LLC(6.32%)等
Aclaris Therapeutics | SC 13G:超過5%持股股東披露文件-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%)等
Aclaris Therapeutics | 4:持股變動聲明-董事 Mehra Anand
Aclaris Therapeutics | 3:首次持股聲明-高管 Davis Hugh M.
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Kenneth Griffin(0.5%),Citadel Advisors LLC(0.3%)等
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Millennium Management LLC(4.2%),Millennium Group Management LLC(4.2%)等
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | 4:持股變動聲明-高管 Balthaser Kevin
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
Aclaris Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(2.9%)
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
Aclaris Therapeutics | 4:持股變動聲明-高管 Walker Neal
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
Aclaris Therapeutics | 4:持股變動聲明-股東 Leonard Braden Michael
暫無數據
暫無數據